GIP
Granite Investment Partners Portfolio holdings
AUM
$2.05B
1-Year Return
24.71%
This Quarter Return
+18.54%
1 Year Return
+24.71%
3 Year Return
+102.95%
5 Year Return
+227.49%
10 Year Return
+874.82%
AUM
$1.76B
AUM Growth
+$395M
(+29%)
Cap. Flow
+$188M
Cap. Flow
% of AUM
10.65%
Top 10 Holdings %
Top 10 Hldgs %
15.75%
Holding
384
New
50
Increased
209
Reduced
59
Closed
31
Top Buys
| 1 |
RE/MAX Holdings
RMAX
|
$15.3M |
| 2 |
HSKA
Heska Corp
HSKA
|
$13.9M |
| 3 |
LivePerson
LPSN
|
$13.6M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$13.3M |
| 5 |
CMO
Capstead Mortgage Corp.
CMO
|
$12.9M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$19.5M |
| 2 |
Phibro Animal Health
PAHC
|
$13.5M |
| 3 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
$13.4M |
| 4 |
MB
MINDBODY, Inc. Class A Common Stock
MB
|
$12.2M |
| 5 |
Evolent Health
EVH
|
$11.7M |
Sector Composition
| 1 | Technology | 18.67% |
| 2 | Healthcare | 17.58% |
| 3 | Industrials | 15.57% |
| 4 | Financials | 9.68% |
| 5 | Consumer Discretionary | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
SI-BONE Inc
SIBN
$703M
| $851K | 0.05% |
+45,151
| New | +$851K |
|
|
IPHS
252
DELISTED
Innophos Holdings, Inc.
IPHS
| $851K | 0.05% |
28,219
+1,178
| +4% | +$35.5K |
|
|
AXNX
253
DELISTED
Axonics, Inc. Common Stock
AXNX
| $848K | 0.05% |
+35,403
| New | +$848K |
|
254
ConocoPhillips
COP
$116B
| $846K | 0.05% |
12,672
| – | – |
|
255
Cytosorbents Corp
CTSO
$60.6M
| $837K | 0.05% |
110,530
+51,679
| +88% | +$391K |
|
256
GE Aerospace
GE
$296B
| $820K | 0.05% |
16,473
+9,774
| +146% | +$487K |
|
|
VAPO
257
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $811K | 0.05% |
+5,158
| New | +$811K |
|
258
IBM
IBM
$232B
| $804K | 0.05% |
5,957
| – | – |
|
|
LOGM
259
DELISTED
LogMein, Inc.
LOGM
| $772K | 0.04% |
9,644
+1,775
| +23% | +$142K |
|
|
ASPU
260
DELISTED
ASPEN GROUP, INC.
ASPU
| $760K | 0.04% |
142,603
+75,854
| +114% | +$404K |
|
261
Global Water Resources
GWRS
$269M
| $757K | 0.04% |
77,156
+36,066
| +88% | +$354K |
|
|
LOAN
262
Manhattan Bridge Capital
LOAN
$61.5M
| $755K | 0.04% |
118,882
+55,566
| +88% | +$353K |
|
263
Inogen
INGN
$219M
| $747K | 0.04% |
7,836
+3,157
| +67% | +$301K |
|
|
WBA
264
DELISTED
Walgreens Boots Alliance
WBA
| $747K | 0.04% |
11,811
| – | – |
|
265
NVE Corp
NVEC
$323M
| $746K | 0.04% |
7,624
+3,564
| +88% | +$349K |
|
266
Travelers Companies
TRV
$62B
| $743K | 0.04% |
+5,415
| New | +$743K |
|
267
Identive
INVE
$90.6M
| $740K | 0.04% |
+146,975
| New | +$740K |
|
268
OptimizeRx
OPRX
$349M
| $734K | 0.04% |
57,748
+26,987
| +88% | +$343K |
|
269
Pfizer
PFE
$141B
| $730K | 0.04% |
18,125
-439
| -2% | -$17.7K |
|
270
Silicon Laboratories
SLAB
$4.45B
| $729K | 0.04% |
9,014
+1,087
| +14% | +$87.9K |
|
271
Lifecore Biomedical
LFCR
$282M
| $727K | 0.04% |
59,219
+15,572
| +36% | +$191K |
|
272
Neuronetics
STIM
$214M
| $722K | 0.04% |
+47,364
| New | +$722K |
|
273
Riverview Bancorp
RVSB
$106M
| $719K | 0.04% |
98,321
+46,407
| +89% | +$339K |
|
274
Hubbell
HUBB
$23.2B
| $718K | 0.04% |
6,084
-192
| -3% | -$22.7K |
|
275
Paychex
PAYX
$48.7B
| $713K | 0.04% |
8,893
-600
| -6% | -$48.1K |
|